Claudia Saraceno
Overview
Explore the profile of Claudia Saraceno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Girolamo G, Leone S, DAddazio M, Toffol E, Martinelli A, Archetti D, et al.
Riv Psichiatr
. 2025 Feb;
60(1):10-21.
PMID: 39912360
Purpose: Treatments for mental disorders, such as pharmacotherapy and psychosocial interventions, do not always guarantee symptomatic remission. The effectiveness of Physical Activity (PA) in improving the psychophysical health of individuals...
2.
de Girolamo G, Leone S, DAddazio M, Toffol E, Martinelli A, Bellini S, et al.
Trials
. 2024 Oct;
25(1):685.
PMID: 39415283
Background: Current treatments for mental disorders, like pharmacotherapy or psychological approaches, do not lead to full remission in all individuals. Physical activity (PA) is effective at improving psycho-physical health in...
3.
Saraceno C, Cervellati C, Trentini A, Crescenti D, Longobardi A, Geviti A, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125924
Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the two major neurodegenerative diseases causing dementia. Due to similar clinical phenotypes, differential diagnosis is challenging without specific biomarkers. Beta-site Amyloid Precursor...
4.
Longobardi A, Bellini S, Nicsanu R, Pilotto A, Geviti A, Facconi A, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000564
Alzheimer's disease (AD) and Frontotemporal lobar degeneration (FTLD) represent the most common forms of neurodegenerative dementias with a highly phenotypic variability. Herein, we investigated the role of genetic variants related...
5.
Saraceno C, Pagano L, Lagana V, Geviti A, Bagnoli S, Ingannato A, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000146
Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD) are the two major neurodegenerative diseases with distinct clinical and neuropathological profiles. The aim of this report is to conduct a population-based investigation...
6.
Longobardi A, Catania M, Geviti A, Salvi E, Vecchi E, Bellini S, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38256197
The accumulation of protein aggregates defines distinct, yet overlapping pathologies such as Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). In this study, we investigated ATG5,...
7.
Gonzalez-Ortiz F, Turton M, Kac P, Smirnov D, Premi E, Ghidoni R, et al.
Brain
. 2022 Dec;
146(3):1152-1165.
PMID: 36572122
Blood-based biomarkers for amyloid beta and phosphorylated tau show good diagnostic accuracies and agreements with their corresponding CSF and neuroimaging biomarkers in the amyloid/tau/neurodegeneration [A/T/(N)] framework for Alzheimer's disease. However,...
8.
Cimini S, Bellini S, Saraceno C, Benussi L, Ghidoni R, Giliani S, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430231
Frontotemporal lobar degeneration (FTLD) is a complex disease, characterized by progressive degeneration of frontal and temporal lobes. Mutations in progranulin () gene have been found in up to 50% of...
9.
Rossi G, Salvi E, Benussi L, Mehmeti E, Geviti A, Bellini S, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361641
Genetic frontotemporal lobar degeneration (FTLD) is characterized by heterogeneous phenotypic expression, with a disease onset highly variable even in patients carrying the same mutation. Herein we investigated if variants in...
10.
Bellini S, Saraceno C, Benussi L, Geviti A, Longobardi A, Nicsanu R, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142612
Emerging data suggest the roles of endo-lysosomal dysfunctions in frontotemporal lobar degeneration (FTLD) and in other dementias. Cathepsin D is one of the major lysosomal proteases, mediating the degradation of...